The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes
- 1 January 1987
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 34 (2) , 155-166
- https://doi.org/10.1016/0163-7258(87)90009-x
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexesChemico-Biological Interactions, 1987
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Binding of platinum compounds to nucleic acids with respect to the anti‐tumor activity ofcis‐diamminedichloroplatinum(II) and derivativesRecueil des Travaux Chimiques des Pays-Bas, 1983
- Comparison of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA by a simple filter binding assayBiochemical and Biophysical Research Communications, 1982
- The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cellsChemico-Biological Interactions, 1982
- Preliminary characterization of the adducts formed between the antitumor compound cis-Pt(NH3)2Cl2 and DNABiochemical and Biophysical Research Communications, 1982
- The nature of inactivating lesions produced by platinum (II) complexes in phage λ DNAChemico-Biological Interactions, 1980
- Platinum-DNA crosslinking: platinum antitumor drug interactions with native lambda bacteriophage DNA studied using a restriction endonucleaseBiochimie, 1978
- Resolution of α, β and γ DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt(NH3)2Cl2. Evidence for preferential drug binding by GpG sequences of DNAJournal of Molecular Biology, 1976
- Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosineNature, 1974